How much does ribociclib cost? Is it covered by medical insurance?

Ribociclib, English nameRibociclib, is an important drug for the treatment of breast cancer. It is a kinase inhibitor specifically designed to treat hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer. The main mechanism of action of ribociclib is by inhibiting the activity of cyclin-dependent kinases 4 and 6, thereby effectively preventing cancer cells from entering the S phase from the G1 phase, thereby inhibiting their division and proliferation. This discovery is considered a major breakthrough in the field of anti-cancer because it can directly intervene in the life cycle of cancer cells and reduce their destructive power on the patient's body.

In clinical applications, ribociclib is often used in combination with aromatase inhibitors as the initial endocrine therapy for postmenopausal women. Studies have shown that this combination therapy can significantly reduce the risk of disease progression and extend patients' progression-free survival compared with traditional treatments. Specifically, ribociclib can reduce the proliferation rate of cancer cells and reduce tumor volume, thereby alleviating patients' symptoms and improving their quality of life.

In addition, the administration method of ribociclib is relatively convenient. It is administered orally, once a day, and is taken continuously for 21 days and then stopped for 7 days, with a cycle of 28 days. This cyclical medication pattern helps reduce patients’ burden of long-term medication while ensuring that the drug can continue to exert its efficacy in the body.

Ribociclibis currently on the market in China, and the domestic price is aboutaround 8,000 yuan. It is understood that the original drug of Ribociclib is available overseas. The original drug of Ribociclib is available in Europe in two specifications. The price of 200mg*21 tablets is about 22,000 yuan per box. In addition, the original research version of ribociclib is available in India with a price of about 3,000 yuan per box. Ribociclib marketed in Europe and India are both original research versions of Ribociclib, but the regions where they are marketed are different.

In general, ribociclib occupies an important position in the field of breast cancer treatment with its unique anti-cancer mechanism and superior therapeutic effect, bringing new hope to many patients.